GW&K Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
GW&K Investment Management's LLY Position: Q2 2026 in Review
GW&K Investment Management reduced its Eli Lilly (LLY) stake by 0.79% in Q2 2026, selling an estimated $171K and leaving 20,866 shares worth $25M. The position accounts for 0.2% of the portfolio, ranked #183.
GW&K Investment Management first reported a position in LLY in Q1 2022 and has held it in 16 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- GW&K Investment Management held 20,866 shares of Eli Lilly worth $25M as of Q2 2026.
- GW&K Investment Management sold 167 Eli Lilly shares in Q2 2026, an estimated $171K.
- Eli Lilly made up 0.2% of GW&K Investment Management's portfolio in Q2 2026, its #183 holding.
- GW&K Investment Management first reported a position in Eli Lilly in Q1 2022 and has held it in 16 quarters since.
- 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.